ORCHARD PARK, N.Y., June 15 /PRNewswire-FirstCall/ -- MINRAD International, Inc. today announced it has closed upon a line of credit with First Niagara Bank for $5,000,000. The line will be used to fund the working capital needs of the Company.
Contact: Timothy Sheehan, VP - Corporate Development tsheehan@minrad.com (716) 855-1068 www.minrad.com
About the Company
MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines. The real-time image guidance products facilitate minimally invasive surgery especially for pain management and have broad applications in orthopedics, neurosurgery, and interventional radiology. These devices enable medical professionals to improve the accuracy of interventional procedures and reduce radiation exposure. MINRAD International also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. Additional information can be found at the company’s website, www.minrad.com.
MINRAD International, Inc.
CONTACT: Timothy Sheehan, VP - Corporate Development of MINRADInternational, Inc., +1-716-855-1068, tsheehan@minrad.com
Web site: http://www.minrad.com/
